External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

European Urology

Volumn 56, Issue 1, 2009, Pages 113-122

  van Onna, Ilze E W ^a   Oddens, Jorg R ^b   Kok, Esther T ^a   van Moorselaar, R Jeroen A ^c   Bosch, J L H Ruud ^a   Battermann, Jan J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Bladder preservation; Brachytherapy; Interstitial radiotherapy; Iridium 192

Indexed keywords

BCG VACCINE; IRIDIUM 192;

ADULT; AGED; ARTICLE; ASPLENIA; BLADDER CANCER; BLADDER FUNCTION; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; CYSTITIS; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HYDRONEPHROSIS; ILEAL CONDUIT; ILEUS; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MALE; NEPHROSTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RECURRENT CANCER; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; CARCINOMA; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDRONEPHROSIS; ILEUS; IRIDIUM RADIOISOTOPES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; URINARY INCONTINENCE, URGE;

EID: 67349201379     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.07.043     Document Type: Article

References (30)

1. Schoenberg M.P., and Gonzalgo M.L. Management of invasive and metastatic bladder cancer. In: Wein A.J., Kavoussi L.R., Novick A.C., Partin A.W., and Peters C.A. (Eds). Campbell-Walsh urology (2007), Saunders, Philadelphia, PA 2468-2478
2. Chahal R., Sundaram S.K., Iddenden R., et al. A study of the morbidity, mortality, and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 43 (2003) 246-257
3. Fokdal L., Hoyer M., and von der Masse H. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol 43 (2004) 749-757
4. Solsona E., Iborra I., Ricos J.V., et al. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term follow-up of a prospective study. J Urol 159 (1998) 95-98
5. Herr H.W., Bajorin D.F., and Scher H.I. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome. J Clin Oncol 16 (1998) 1298-1301
6. George L., Bladou F., Bardou V.J., et al. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 64 (2004) 488-493
7. Rodel C., Weiss C., and Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 24 (2006) 5536-5544
8. Feneley M.R., and Schoenberg M. Bladder-sparing strategies for transitional cell carcinoma. Urology 56 (2000) 549-560
9. Wijnmaalen A., Helle P.A., Koper P.C., et al. Muscle-invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192. Int J Radiat Oncol Biol Phys 39 (1997) 1043-1052
10. Van der Steen-Banasik E.M., Visser A.G., Reinders J.G., et al. Saving bladders with brachytherapy: implantation technique and results. Int J Radiat Oncol Biol Phys 53 (2002) 622-629
11. Van Poppel H., Lievens Y., van Limbergen E., et al. Brachytherapy with iridium-192 for bladder cancer. Eur Urol 37 (2000) 605-608
12. Mazeron J.J., Marinello G., Leung S., et al. Treatment of bladder tumors by iridium 192 implantation. The Creteil technique. Radiother Oncol 4 (1985) 111-119
13. Pos F., Horenblas S., Dom P., et al. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?. Int J Radiat Oncol Biol Phys 61 (2005) 678-686
14. Rozan R., Albuisson E., Donnarieix D., et al. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 24 (1992) 469-477
15. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York, NY
16. Battermann J.J., and Boon T.A. Interstitial therapy in the management of T2 bladder tumors. Endocurietherapy/Hyperthermia Oncol 4 (1988) 1-6
17. Brenner D.J., and Hall E.J. Conditions for the equivalence of continuous to pulsed, low-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 20 (1991) 181-190
18. Kuczyk M., Turkeri L., Hammerer P., et al. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?. Eur Urol 44 (2003) 57-64
19. Montie J.E. Against bladder sparing: surgery. J Urol 162 (1999) 452-455
20. Pernot M., Hubert J., Guillemin F., et al. Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192). Radiother Oncol 38 (1996) 115-120
21. Gonzalez D., van der Veen H.J., Ypma A.F., et al. Brachytherapy for urinary bladder cancer. Arch Esp Urol 52 (1999) 655-661
22. Gschwend J.E., Dahm P., and Fair W.R. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41 (2002) 440-448
23. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
24. Solsona E., Iborra I., Rubio J., et al. Late oncological occurrences following radical cystectomy in patients with bladder cancer. Eur Urol 43 (2003) 489-494
25. Nieuwenhuijzen J.A., Pos F., Moonen L.M.F., Hart A.A.M., and Horenblas S. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol 48 (2005) 239-245
26. Lugagne P.M., Hervé J.M., Lebret T., Barré P., Mollier S., and Botto H. Ureteroileal implantationin orthotopic neobladder with the Le Duc-Camey mucosal-through technique: risk of stenosis and long-term follow-up. J Urol 158 (1997) 765-767
27. Horikawa Y., Kumazawa T., Narita S., et al. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy. Int J Clin Oncol 12 (2007) 131-136
28. Stein J.P., Quek M.L., and Skinner D.G. Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 97 (2006) 232-237
29. Gofrit O.N., Zorn K.C., Steinberg G.D., Zagaja G.P., and Shalhav A.L. The Will Rogers phenomenon in urological oncology. J Urol 179 (2008) 28-33
30. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur Urol 48 (2005) 202-206